Your search found 2 Results
Programmatic and research considerations for hormonal contraception for women at risk of HIV and women living with HIV.
Geneva, Switzerland, WHO, Department of Reproductive Health and Research, 2012 May.  p. (Policy Implications; WHO/RHR/12.09)Between 31 January and 2 February 2012, the World Health Organization (WHO) convened a meeting of experts to discuss recent research on use of hormonal contraception by women at high risk of HIV and those currently living with HIV and its implications. The purpose of the meeting was to review all available published evidence on the relationship between the use of hormonal contraceptives and the risk of HIV acquisition, HIV disease progression, and HIV transmission to uninfected partners, and to determine whether any change in the WHO recommendations on hormonal contraceptive use by women at high risk of, or living with, HIV-infection was needed. During the discussion on the balance of risks and benefits of hormonal contraceptive use among women at high risk of, or living with, HIV infection, multiple programmatic and research issues emerged, including priority knowledge gaps. This brief serves to highlight actions that programmes providing sexual and reproductive health and HIV-prevention services should undertake, in order to complement the Consultation’s recommendations. Directions for future research to address current gaps are noted. (Excerpts)
Creating common ground in Asia: women's perspectives on the selection and introduction of fertility regulation technologies.
Geneva, Switzerland, World Health Organization [WHO]. Special Programme of Research, Development and Research Training in Human Reproduction, 1994. 45 p.Participants from Bangladesh, India, Indonesia, the Philippines, and other countries with which WHO's Special Programme of Research, Development, and Research Training in Human Reproduction collaborates and in which women's groups are active attended the Asian regional meeting on Women's Perspectives on the Research and Introduction of Fertility Regulation Technologies in February 1991. The meeting aimed to establish a dialogue between women's groups and researchers, policymakers, and family planning service providers. Other objectives included defining women's needs and viewpoints on reproductive health and fertility regulating technologies and identifying appropriate follow-up activities which would form a basis for regional networking. WHO's Special Programme of Research, Development, and Research Training in Human Reproduction published a report of the meeting. The meeting consisted of plenary sessions, group work, and keynote presentations. Presentations addressed women's realities, policy considerations, research, and service provision. Topics concerning women's realities were community attitudes towards fertility and its control, women's autonomy, health status, and family planning services. Presentations on policy considerations covered: taking users into account, objectives of family planning programs, participation in decision making, and men's responsibility. Redefining safety and acceptability as well as research on female barrier methods were addressed during presentations on research. The report presents proposals for action for Bangladesh, India, Indonesia, and the Philippines. Meeting participants reached a consensus on recommendations addressing policy, research, services, and WHO. The report concludes with a list of participants and a list of papers presented.